Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 1, 1997, Pages 17-22

  Díaz, Orlando ^a   Barberà, Joan A ^c   Marrades, Ramón ^c   Chung, K Fan ^c   Roca, Josep ^b   Rodriguez Roisin, Robert ^c  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CLÍNIC   (Spain)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; IPRATROPIUM BROMIDE; SALBUTAMOL; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AIRWAY; ARTICLE; ASTHMA; BLOOD GAS ANALYSIS; BRONCHODILATATION; BRONCHOSPASM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; GAS EXCHANGE; HUMAN; INFLAMMATION; INHALATIONAL DRUG ADMINISTRATION; LUNG RESISTANCE; LUNG VENTILATION PERFUSION RATIO; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030842117     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.1.9610100     Document Type: Article

References (28)

1. Henson, P. M., P. J. Barnes, and S. P. Banks-Schlegel. 1977. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. Am. Rev. Respir. Dis. 145:726-731.
2. Chung, K. F. 1992. Platelet-activating factor in inflammation and pulmonary disorders. Clin. Sci. 83:127-138.
3. Rodriguez-Roisin, R., M. A. Félez, K. F. Chung, J. A. Barberà, P. D. Wagner, A. Cobos, P. J. Barnes, and J. Roca. 1994. Platelet-activating factor causes ventilation-perfusion mismatch in man. J. Clin. Invest. 93:188-194.
4. Félez, M. A., J. Roca, J. A. Barbera, C. Santos, M. A. Rotger, K. F. Chung, and R. Rodriguez-Roisin. 1994. Inhaled platelet-activating factor worsens gas exchange in mild asthma. Am. J. Respir. Crit. Care Med. 150:369-373.
5. Rodriguez-Roisin, R., and J. Roca. 1994. Contributions of multiple inert gas elimination technique to pulmonary medicine. 3: Bronchial asthma. Thorax 49:1027-1033.
6. Wagner, P. D., G. Hedenstierna, and R. Rodriguez-Roisin. 1996. Gas exchange, expiratory flow obstruction and the clinical spectrum of asthma. Eur. Respir. J. 9:1278-1282.
7. Roca, J., M. A. Félez, K. F. Chung, J. A. Barbera, M. Rotger, C. Santos, and R. Rodriguez-Roisin. 1995. Salbutamol inhibits pulmonary effects of platelet-activating factor in man. Am. J. Respir. Crit. Care Med. 151: 1740-1745.
8. Masclans, J. R., J. A. Barbera, W. MacNee, J. Pavia, C. Piera, F. Lomeña, K. Fan Chung, J. Roca, and R. Rodriguez-Roisin. 1996. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans. Am. J. Respir. Crit. Care Med. 154:529-532.
9. McDonald, D. M. 1987. Neurogenic inflammation in the respiratory tract: actions of the sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am. Rev. Respir. Dis. 136:S65-S67.
10. McDonald, D. M. 1990. The ultrastructure and permeability of tracheobronchial vessels in health and disease. Eur. Respir. J. 3(Suppl. 12):572s-585s.
11. Roca, J., J. Sanchis, A. Agustí-Vidal, F. Segarra, D. Navajas, R. Rodriguez-Roisin, P. Casan, and S. Sans. 1986. Spirometric reference values from a Mediterranean population. Bull. Eur. Physiopathol. Respir. 22:217-224.
12. Roca, J., and P. D. Wagner. 1994. Contributions of multiple inert gas elimination technique to pulmonary medicine. 1: Principles and information content of the multiple inert gas elimination technique. Thorax 49:815-824.
13. Gomm, S. A., N. P. Keaney, L. P. Hunt, S. C. Allen, and T. P. Stretton. 1983. Dose-response comparison of ipratropium bromide from a metered-dose inhaler and dry jet nebulization. Thorax 38:297-301.
14. Gale, G. E., J. Torre-Bueno, R. E. Moon, H. A. Saltzman, and P. D. Wagner. 1985. Ventilation-perfusion inequality in normal humans during exercise. J. Appl. Physiol. 58:978-988.
15. Chung, K. F., and P. J. Barnes. 1989. Effects of platelet-activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. Thorax 44:108-115.
16. Smith, L. J., A. E. Rubin, and R. Patterson. 1988. Mechanism of platelet activating factor-induced bronchoconstriction in humans. Am. Rev. Respir. Dis. 137:1015-1019.
17. O'Donnell, S. R., and C. J. K. Barnett. 1987. Microvascular leakage due to platelet-activating factor in guinea pig trachea and bronchi. Eur. J. Pharmacol. 138:385-396.
18. Yager, D., J. Butler, J. Bastacky, E. Israel, G. Smith, and J. M. Drazen. 1989. Amplification of airway constriction due to liquid filling of airway interstices. J. Appl. Physiol. 66:2873-2884.
19. Ballester. E., A. Reyes, J. Roca, R. Guitart, P. D. Wagner, and R. Rodriguez-Roisin. 1989. Ventilation-perfusion mismatching in acute severe asthma: effects of salbutamol and 100% oxygen. Thorax 44:258-267.
20. Ballester, E., J. Roca, L. I. Ramis, P. D. Wagner, and R. Rodriguez-Roisin. 1990. Pulmonary gas exchange in severe chronic asthma: response to 100% oxygen and salbutamol. Am. Rev. Respir. Dis. 141: 558-562.
21. 2-adrenoceptor agonists against platelet activating factor-induced airway microvascular leakage in the guinea pig. Agents Actions 40:50-56.
22. Sulakvelidze, I., and D. M. McDonald. 1994. Antiedema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am. J. Respir. Crit. Care Med. 149:232-238.
23. Tokuyama, K., J. O. Lötvall, C. G. Löfdahl, P. J. Barnes, and K. F. Chung. 1991. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur. J. Pharmacol. 193:35-39.
24. Sakai, A., S. W. Chang, and N. F. Voelkel. 1989. Importance of vasoconstriction in lipid mediator-induced pulmonary edema. J. Appl. Physiol. 66:2667-2674.
25. Chen, Ch. R., N. F. Voelkel, and S. W. Chang. 1990. PAF potentiates protamine-induced lung edema: role of pulmonary venoconstriction. J. Appl. Physiol. 68:1059-1068.
26. Toga, H., S. Hibler, B. O. Ibe, and U. Raj. 1992. Vascular effects of platelet-activating factor in lambs: role of cyclo- and lipooxygenase. J. Appl. Physiol. 73:2559-2566.
27. 4 receptor antagonist 1CI-204.219 in normal subjects. Am. Rev. Respir. Dis. 147: 215-217.
28. Persson, C. G. A. 1988. Plasma exudation and asthma. Lung 166:1-23.